Biopharma & Life Sciences
NRC Health Executive Compensation (FY25)
NRC · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): June 29, 2026
188 figures on this page: 177 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Michael Hays → Trent Green
CEO pay ratio: 2.2:1 → 137:1
Frequently asked questions
Answers drawn from the data on this page.
Who is NRC Health's chief executive and what were they paid?
Trent Green, Chief Executive Officer, received $11,961,900 in total compensation for fiscal 2025.
What was NRC Health's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 85.3% of votes cast including abstentions in favor at the meeting held June 23, 2026.
What is NRC Health's chief executive pay ratio?
The company reported a chief executive pay ratio of 137:1 for fiscal 2025, against median employee compensation of $87,276.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Jona Raasch Chief Operating Officer | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Kevin Karas Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Helen Hrdy Chief Growth Officer | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Michael Hays Chief Executive Officer and President | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Kevin Karas Former Senior Vice President-Finance, Chief Financial Officer, Treasurer, and Secretary Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Helen Hrdy Chief Customer Officer | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Jona Raasch Former Chief Operating Officer Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Michael Hays Chief Executive Officer and President | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Christophe Louvion Former Chief Product Technology Officer Departed during or after this year | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Helen Hrdy Chief Operating Officer | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Jason Hahn Former Chief Revenue Officer Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Kevin Karas Former Senior Vice President-Finance, Chief Financial Officer, Treasurer, and Secretary Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
Linda Stacy Former Principal Financial Officer, Principal Accounting Officer, and Secretary and Current Principal Financial Officer Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
Michael Hays Chief Executive Officer, President | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Trent Green Chief Executive Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Shane Harrison Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Helen Hrdy EVP & Chief Operating Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Andy Monnich EVP & Chief Corporate Development Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jason Rau Executive Vice President, Sales | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Michael Hays Chair; Former Chief Executive Officer, President Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Linda Stacy Former Interim Principal Financial Officer Departed during or after this year Served on an interim basis | ◇ | — | — | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Andy Monnich | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Helen L. Hrdy | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Shane Harrison | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Trent Green | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Andy Monnich | RSU | ◇ | ◇ | — | — |
| Michael Hays | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Shane Harrison | RSU | ◇ | ◇ | — | — |
| Helen Hrdy | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Trent Green | RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
John N. Nunnelly Lead independent director | ◇ | — | ◇ | — | — | — | ◇ |
Penny A. Wheeler | ◇ | — | ◇ | — | — | — | ◇ |
Donald M. Berwick | ◇ | — | ◇ | — | — | — | ◇ |
Parul Bhandari | ◇ | — | ◇ | — | — | — | ◇ |
Stephen H. Lockhart | ◇ | — | ◇ | — | — | — | ◇ |
Trent Green and Michael D. Hays served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Board meeting fee | ◇ |
Equity is delivered as Options.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 23, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 7, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 8, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 11, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 18, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | June 29, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 21, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 29, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 30, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 9, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | May 11, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact NRC Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
188 figures on this page: 177 cited to the filing that reported them, 11 calculated from figures it prints.
177 cited to the filing
11 calculated from the filing
Documents cited
- 0001437749-26-021938Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001437749-26-0157752025 Director Compensation · 2025 Summary Compensation Table · CEO Pay Ratio · Grants of Plan-Based Awards · and 1 more section
- 0001437749-25-015965
- 0001437749-25-0116932024 Summary Compensation Table
- 0001437749-24-016208
- 0001437749-24-0117312023 SUMMARY COMPENSATION TABLE
- 0001437749-23-014369
- 0001437749-23-0096082022 SUMMARY COMPENSATION TABLE
- 0001437749-22-013292
- 0001437749-21-016301
- 0001437749-20-011616
- 0001437749-19-011113
- 0001437749-18-011058
- 0001437749-17-008962
- 0001437749-16-031944
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “NRC Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/NRC (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about NRC Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Biopharma & Life Sciences rankings
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}